Tag: Ascensia Diabetes Care
In brief: UHC’s new capitated arrangement, NCPA’s cyberattack request
May 3, 2024HME News Staff
MINNEAPOLIS – UnitedHealthcare has entered into a capitated arrangement with Synapse Health for standard DME in Georgia and North Carolina for its Medicare Advantage plan members enrolled in HMO and PPO plans.
The change, announced on UHC’s website on May 1, is effective Aug. 1.
DME providers will need to join the Synapse Health network to continue to provide standard DME for these plan members. Synapse Health will reach out to providers with details about joining...
Ascensia receives iCGM designation for Eversense
May 1, 2024HME News Staff
PARSIPPANY, N.J. – Ascensia Diabetes Care and Senseonics Holdings have received an integrated CGM designation from the U.S. Food and Drug Administration. The designation indicates that the Eversense iCGM product can integrate with compatible medical devices, including insulin pumps. “Managing diabetes is all about personal choice and finding the options that best support an individual to live a healthier, less interrupted life,” said Brian Hansen, president of CGM at Ascensia. “For...
Health care goes OTC
April 26, 2024Theresa Flaherty, Managing Editor
As is par for the course these days, my inbox this month has been filled with diabetes tech announcements: Edgepark is adding a new insulin delivery system to its portfolio, Insulet’s Omnipod is fueling growth and Ascensia is expanding access to its Eversense device by extending its PASS program, which offers a substantial discount for users.
That last one is key: All the technology in the world won’t help if it’s too expensive for people to acquire. And this stuff is expensive...
In brief: OCR investigation, NHIA recommendations, SuperCare pilot
March 15, 2024HME News Staff
WASHINGTON – The Office of Civil Rights, which administers and enforces HIPAA private, security and breach notification rules, has announced that it will investigate the cyberattack on Change Healthcare to determine whether patient health information was compromised.
The agency will also investigate whether Change Healthcare and UnitedHealth Group were compliant with HIPAA rules.
“We are committed to ensuring access to care, while enforcing laws that bolster patient...
Ascensia extends PASS program
March 14, 2024HME News Staff
PARSIPPANY, N.J. – Ascensia Diabetes Care and Senseonics Holdings will extend the Eversense Payment Assistance and Simple Savings (PASS) Program. Designed to help people in the U.S. access the Eversense E3 CGM System more affordably, the program offers major savings for eligible individuals looking to experience the unique benefits of the only long-term CGM system available. Eligible individuals will pay only $99 out of pocket for an unlimited number of six-month Eversense E3 systems under...
Ascensia announces coverage expansion for CGM system
February 12, 2024HME News Staff
PARSIPPANY, N.J. – Ascensia Diabetes Care and Senseonics Holdings have announced that Medicare has significantly expanded access to the Eversense E3 CGM System with the implementation of local coverage determinations that provide access to implantable CGM for basal-only patients. Medicare coverage has been expanded for implantable CGMs to include all people with diabetes using insulin, removing the previous requirement for multiple inulin administrations per day. Coverage has also been updated...
Ascensia names leader for CGM business
February 6, 2024HME News Staff
TOKYO – PHC Holdings Corp., the parent company of Ascensia Diabetes Care, and Senseonics Holdings have announced that diabetes industry veteran Brian Hansen has been appointed to the newly created role of president of CGM at Ascensia Diabetes Care effective today, Feb. 6, 2024. Hansen will be responsible for the global commercialization and growth of the Eversense CGM, which is currently available in the U.S. and select European markets. “Eversense is a game-changer for people with diabetes...
Ascensia featured in film series
December 6, 2023HME News Staff
PARSIPPANY, N.J. – Ascensia Diabetes Care is participating in a new film series featuring the story of patient advocate and Eversense user Troy Ita. The “Connecting the Dots” series, which brings into focus the evolution of medical technologies, includes Ascensia’s mini-documentary style video focusing on Troy’s journey with diabetes and how the evolution in continuous glucose monitoring technology has supported him to live a fuller, less interrupted life. In particular,...
Ascensia, Senseonics launch ad campaign
October 11, 2023HME News Staff
PARSIPPANY, N.J., and GERMANTOWN, Md. – Ascensia Diabetes Care and Senseonics Holdings have launched a new U.S. advertising and marketing campaign for the Eversense E3 CGM System. The “CGM for Real Life” campaign seeks to drive awareness of the Eversense E3, a six-month, implantable sensor, as well as the everyday challenges people with diabetes face. “This campaign is designed to challenge the status quo in continuous glucose monitoring, which for too long has meant self-insertion...
Ascensia: ‘This is Diabetes, This is Real’
September 19, 2023HME News Staff
PARSIPPANY, N.J. – Ascensia Diabetes Care, owner of the CONTOUR blood glucose monitoring system portfolio and exclusive distributor of the Eversense continuous glucose monitoring system, has opened submissions for its art and photo competition in support of World Diabetes Day 2023. The theme of this year’s competition is “This is Diabetes, This is Real,” aiming to capture the challenges, successes and day-to-day realities of people living with diabetes. “For our 2023...